Felecia L. Stern

Felecia L. Stern graduated cum laude from the University of Pennsylvania Law School in 1992, where she served as a comments editor on the University of Pennsylvania Law Review.  She received her bachelor’s degree in 1989 from Cornell University.

Following law school, Ms. Stern served as a law clerk to the Honorable Francis X. Altimari of the United States Court of Appeals for the Second Circuit.  She then spent ten years working at Simpson Thacher & Bartlett LLP, where she represented defendant corporations in complex commercial litigations, including many securities fraud class actions and shareholders’ rights litigations.  She was also involved in a number of SEC and other governmental investigations.

Ms. Stern joined the Firm in 2002, and concentrates her practice in securities fraud actions, mass torts and consumer protection.  She also has significant appellate experience and has worked on important securities appeals, including In re Initial Public Offering Securities Litigation, No. 21 MC 92 (S.D.N.Y.), one of the largest securities class actions in history, which recently settled for $586 million.  She is a member of the Firm’s Supreme Court and Appellate Practice Group.

Since joining the Firm, Ms. Stern has been involved in several class actions that were successfully resolved on behalf of aggrieved investors and consumers.  Most recently, Ms. Stern was one of the partners in charge of the day-to-day management of In re Marsh & McLennan Cos., Inc. Securities Litigation, No. 04-CV-8144 (CM) (S.D.N.Y.), in which a settlement of $400 million recently received final approval.  Other successful securities actions Ms. Stern has handled include:  In re Deutsche Telekom A.G. Securities Litigation, No. 00-CV-9475 (S.D.N.Y.) ($120 million); and In re Abercrombie & Fitch Co. Securities Litigation, No. M21-83 (S.D.N.Y.) ($6.05 million).  She also successfully litigated a consumer class action that resulted in the re-labeling of a popular home medical testing device to properly reflect the product’s limitations.

Currently, Ms. Stern is one of two partners recently appointed to head the Firm’s mass tort practice group.  Leveraging her experience in complex and class action litigation along with her experience in medical device litigation, Ms. Stern is now working on a wide array of pharmaceutical and consumer injury cases.  She is currently investigating cases concerning Accutane, Fosamax, Denture Cream, Yasmin, Yaz , pain pump,  Levaquin, transvaginal mesh, Bard Avaulta, Avandia and Chantix.

Ms. Stern is admitted to practice in the State of New York and the United States District Courts for the Southern and Eastern Districts of New York.